Health Science Report Health Science Report
Dr. Joe Glickman, Jr., M.D.
What others are saying:



  • Click here to read the complete testimonials and contact some previous customers by email.

Home

  >

Pap Smear

>

Pap Smear Hpv

>

Pap Smear Classification

Pap Smear Classification

According to pap smear classification there are mild and severe disorders; to prevent them from further development Beta-mannan and antiviral creams are recommended for the vulvar area. If the changes in the cells are severe, cancer is diagnosed. Low/High-grade squamous intraepithelial lesions are precancerous cells. Atypical cells are those that can be classified as neither normal, nor abnormal and are believed to appear due to infections or trauma during childbirth. According to pap smear classification there are mild and severe disorders; to prevent them from further development Beta-mannan and antiviral creams are recommended for the vulvar area.

Just select from the Research Topics on the adjacent gray column for easy viewing of important articles. If this is your first visit, click here for a brief summary of this website.

.

Pap Smear Classification

  -  

Beta-mannan, Vulvar

Women with negative test results can rest assured that there is nothing wrong with the reproductive health. According to Bethesda system, there are 5 types of Papnicolaou tests that describe a condition revealed by the microscopic examination of cells taken from the cervix. According to pap smear classification there are mild and severe disorders; to prevent them from further development Beta-mannan and antiviral creams are recommended for the vulvar area.

Research Topics

Click a topic button below to view related articles:

HPV
Cervical Dysplasia
Genital Warts
Plantar Warts
Genital Herpes
Oral Herpes
Other Conditions

Site Navigation

BBBOnLine Reliability Seal

Solutions for HPV (human papilloma virus), cervical dysplasia, genital warts, genital herpes, and oral herpes is protected by Copyright © 1996-2005 Joe Glickman, Jr., M.D. & Health Science Report™